Global In Vitro Diagnostics (IVD) Industry Outlook to 2024 - Strategic Recommendations are to Focus on Theranostics, Invest in Microbiology System Automation, Reduce the Cost of Diagnostic TestsHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Global In Vitro Diagnostics (IVD) Industry Outlook to 2024 - Strategic Recommendations are to Focus on Theranostics, Invest in Microbiology System Automation, Reduce the Cost of Diagnostic TestsPR NewswireJanuary 8, 2020ReblogShareTweetShareDUBLIN, Jan. 8, 2020 /PRNewswire/ -- The "Global In Vitro Diagnostics (IVD) Market: Analysis By Product (Medical Devices, Reagents and Kits, Services), By Technology, Application, End User, By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024)" report has been added to ResearchAndMarkets.com's offering.Research and Markets LogoMoreThe Global In Vitro Diagnostics Market was valued at USD 61,700.22 Million in the year 2018.As size of old age population is increasing globally, quality healthcare is required. Diagnostics have major role, as majority of clinical decisions are based on diagnostic test result. They assist in providing personalised treatment and drugs are administered to the patient specifically.Additionally, number of patients suffering from chronic and infectious disease are increasing globally, which is primarily powered by unhealthy lifestyle, air and water pollution, genetic modification of disease causing microbes, which is estimated to accelerate the In Vitro Diagnostics Market Growth during the period of 2019-2024.Molecular Diagnostics technology has been estimated to propel the market growth globally mainly because of large number of chronic diseases such as cancer, genetic disease, Non Invasive Prenatal Testing. Also, End User growth rate of home test kits will be high due to ease of testing, cost effectiveness and accuracy of test results obtained.By product type, reagents and kits will have high growth rate, as they get consumed in the diagnostic process and have to be replenished. Also rising investment by leading IVD companies in development and automation of IVD products, according to disease specificity, has been anticipated to spur the market growth during the forecast period.Scope of the ReportGlobal In Vitro Diagnostics Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)In Vitro Diagnostics Market - Size, Growth, Forecast Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics Analysis By Application: Infectious Disease, Non Infectious Disease Analysis By End-user: Hospital, Laboratory, Home Test, Others Analysis By Product - Medical Devices, Reagents & Kits, ServicesRegional Analysis - North America, Latin America, Asia Pacific, EMEA (Actual Period: 2014-2018, Forecast Period: 2019-2024)In Vitro Diagnostics Market - Size, Growth, Forecast Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics Analysis By Application: Infectious Disease, Non Infectious Disease Analysis By End-user: Hospital, Laboratory, Home Test, Others Analysis By Product - Medical Devices, Reagents & Kits, ServicesCountry Analysis - USA, Canada, Germany, UK, Italy, Japan, China, India, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)In Vitro Diagnostics Market - Size, Growth, Forecast Analysis By Technology: Centralised and Point of care, Diabetes Care, Molecular Diagnostics, Tissue Diagnostics Analysis By Application: Infectious Disease, Non Infectious Disease Analysis By End-user: Hospital, Laboratory, Home Test, Others Analysis By Product - Medical Devices, Reagents & Kits, ServicesOther Report HighlightsCompetitive Landscape Leading Companies Key Developments Market Dynamics - Drivers & Restraints Market Trends SWOT AnalysisCompanies ProfiledAbbott Becton-Dickinson Bio-Rad bioMerieux Danaher Ortho Clinical Diagnostics Roche Siemens Healthineers Sysmex Thermofisher ScientificStrategic RecommendationsFocus on Theranostics Investment in Microbiology System Automation Reducing the Cost of Diagnostic TestFor more information about this report visit https://www.researchandmarkets.com/r/jbtst3Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.Media Contact:Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716CisionMoreView original content:http://www.prnewswire.com/news-releases/global-in-vitro-diagnostics-ivd-industry-outlook-to-2024---strategic-recommendations-are-to-focus-on-theranostics-invest-in-microbiology-system-automation-reduce-the-cost-of-diagnostic-tests-300983458.htmlSOURCE Research and MarketsReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextNations take drastic measures as coronavirus outbreak spreadsMarketWatchFragile Economic Recovery in India Faces New Risk from VirusBloombergGlobal coronavirus cases rise as China’s downward trend continuesPA Media: World NewsCitigroup, Goldman, JPMorgan Slash Earnings Estimates for StocksBloombergHere are 5 reasons the stock market is having its worst decline since 2008, and only one of them is the coronavirusMarketWatchBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWoman Who Snorted 550 Times the Usual Dose of LSD Survives and Experiences Dramatic Pain ReliefPeople'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video